<Disease><Name>HAWKINSINURIA</Name><Synonym>4-@HYDROXYPHENYLPYRUVATE HYDROXYLASE DEFICIENCY</Synonym><OMIM><Number>140350</Number><URL>http://omim.org/entry/140350</URL></OMIM><Orphanet><Number>2118</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=2118</URL></Orphanet><Protein><Number>4-hydroxyphenylpyruvate dioxygenase; 4-alpha-hydroxyphenylpyruvate hydroxylase</Number><URL>http://www.uniprot.org/uniprot/P32754</URL></Protein><ExPASy><Number>1.13.11.27</Number><URL>http://enzyme.expasy.org/EC/1.13.11.27</URL></ExPASy><Gene>12q24.31</Gene><ICD>E70.2</ICD><Summary>very rare ;autosomal dominant ;Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene (HPD) are responsible for tyrosinemia type III and hawkinsinuria [Tomoeda K et al. 2000]</Summary><Symptoms><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>3198</id><symptom>ketosis, ketoacidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2065</id><symptom>metabolic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1717</id><symptom>no clinical symptoms (probably) / no clinical  significance</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>4059</id><symptom>radiohumeral synostosis</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2342</id><symptom>skeletal changes, skeletal abnormalities</symptom><category>SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>2157</id><symptom>swimming pool odor</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1584</id><name>4-Hydroxyphenyllactic acid</name><specimen>urine</specimen><value>increased</value><min>1.50</min><max>3.90</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1656</id><name>L-Tyrosine</name><specimen>urine</specimen><value>increased</value><min>4.10</min><max>23.50</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1676</id><name>4-Hydroxyphenylacetic acid</name><specimen>urine</specimen><value>increased</value><min>1.40</min><max>14.60</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1689</id><name>Succinylacetone</name><specimen>urine</specimen><value>normal</value><min>0.60</min><max>4.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1731</id><name>4-Hydroxyphenylpyruvic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>45.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1738</id><name>Succinylacetone</name><specimen>urine</specimen><value>normal</value><min>0.00</min><max>410.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1795</id><name>4-Hydroxyphenylacetic acid</name><specimen>urine</specimen><value>increased</value><min>36.00</min><max>69.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1796</id><name>4-Hydroxyphenyllactic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>470.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1969</id><name>L-Tyrosine</name><specimen>plasma</specimen><value>increased</value><min>34.00</min><max>112.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1970</id><name>L-Tyrosine</name><specimen>plasma</specimen><value>increased</value><min>19.00</min><max>119.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1971</id><name>L-Tyrosine</name><specimen>plasma</specimen><value>increased</value><min>35.00</min><max>107.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>2076</id><name>Succinylacetone</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.02</max><unit>&#956;mol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>2104</id><name>Hawkinsin</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.01</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>71</id><name>4-Hydroxycyclohexylacetic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>68</id><name>4-Hydroxyphenylacetic acid</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>28.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1363</id><name>4-Hydroxyphenylacetic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>59.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>GCMS</method><comment /></metabolite><metabolite><id>1362</id><name>4-Hydroxyphenylacetic acid</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>240.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>675</id><name>4-Hydroxyphenyllactic acid</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>677</id><name>4-Hydroxyphenyllactic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>678</id><name>4-Hydroxyphenyllactic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>7.00</max><unit>mmol/mol creatinine</unit><age>adolescence</age><method /><comment /></metabolite><metabolite><id>674</id><name>4-Hydroxyphenyllactic acid</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>11.50</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>676</id><name>4-Hydroxyphenyllactic acid</name><specimen>urine</specimen><value>increased</value><min>0.30</min><max>5.80</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>680</id><name>4-Hydroxyphenylpyruvic acid</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>682</id><name>4-Hydroxyphenylpyruvic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>683</id><name>4-Hydroxyphenylpyruvic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>66</id><name>4-Hydroxyphenylpyruvic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>679</id><name>4-Hydroxyphenylpyruvic acid</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>21.30</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>72</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>42.00</min><max>115.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>560</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>54.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>563</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>all</age><method /><comment /></metabolite><metabolite><id>1168</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>77.00</min><max>133.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1284</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>blood</specimen><value>increased</value><min>14.00</min><max>62.54</max><unit>&#181;mol/ml</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1285</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>serum</specimen><value>increased</value><min>23.80</min><max>106.32</max><unit>&#181;mol/ml</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>810</id><name>Bicarbonate</name><specimen>blood</specimen><value>decreased</value><min>24.00</min><max>27.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1021</id><name>Bicarbonate</name><specimen>stool</specimen><value>decreased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>420</id><name>Hawkinsin</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.01</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>1527</id><name>Hawkinsin</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.01</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>421</id><name>Hawkinsin</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.01</max><unit>&#956;mol/l</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>475</id><name>Ketone bodies (urine)</name><specimen>urine</specimen><value>normal/inc</value><min>    </min><max>    </max><unit>negative</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1977</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>10.20</min><max>32.60</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>394</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>plasma</specimen><value>increased</value><min>13.00</min><max>161.00</max><unit>&#181;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>559</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>44.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1924</id><name>L-Tyrosine</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>23.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1763</id><name>L-Tyrosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>43.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>793</id><name>pH</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>7.00</max><unit>no unit</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>60</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.35</min><max>7.45</max><unit>no unit</unit><age>child</age><method /><comment /></metabolite><metabolite><id>302</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.20</min><max>7.40</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>303</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.10</min><max>7.30</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>301</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.30</min><max>7.50</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>300</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.10</min><max>7.40</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>70</id><name>Succinylacetone</name><specimen>urine</specimen><value>normal</value><min>0.00</min><max>0.10</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1390</id><name>Succinylacetone</name><specimen>urine</specimen><value>normal</value><min>0.00</min><max>0.10</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>155</id><name>L-Tyrosine</name><specimen>urine</specimen><value>normal</value><min>6.00</min><max>55.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>870</id><name>L-Tyrosine</name><specimen>urine</specimen><value>normal</value><min>9.00</min><max>48.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1553</id><name>L-Tyrosine</name><specimen>urine</specimen><value>normal</value><min>6.00</min><max>26.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1517</id><name>L-Tyrosine</name><specimen>urine</specimen><value>normal</value><min>11.00</min><max>54.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>53</id><name>L-Tyrosine</name><specimen>plasma</specimen><value>increased</value><min>38.00</min><max>147.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>1298</id><name>L-Tyrosine</name><specimen>blood</specimen><value>increased</value><min>29.06</min><max>178.41</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1299</id><name>L-Tyrosine</name><specimen>plasma</specimen><value>increased</value><min>14.00</min><max>115.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite></Metabolites><Literatures><literature><id>3242</id><title>Hawkinsinuria in two unrelated Greek newborns: identification of a novel variant, biochemical findings and treatment</title><author>Thodi G,</author><journal>J Pediatr Endocrinol Metab</journal><year>2015</year><book /><volume>29</volume><number>1</number><pages>15-20</pages><co_aut>et al.</co_aut></literature><literature><id>3243</id><title>Product analysis and inhibition studies of a causative Asn to Ser variant of 4-hydroxyphenylpyruvate dioxygenase suggest a simp</title><author>Brownlee JM,</author><journal>Biochemistry</journal><year>2010</year><book /><volume>49</volume><number>33</number><pages>7218-7226</pages><co_aut>et al.</co_aut></literature><literature><id>3244</id><title>Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III</title><author>Item CB,</author><journal>Mol Genet Metab</journal><year>2007</year><book /><volume>91</volume><number>4</number><pages>379-383</pages><co_aut>et al.</co_aut></literature><literature><id>2476</id><title>Animal models reveal pathophysiologies of tyrosinemias</title><author>Endo F</author><journal>J Nutr Suppl</journal><year>2003</year><book /><volume>133</volume><number>6</number><pages>2063-67S</pages><co_aut>et al.</co_aut></literature><literature><id>1309</id><title>Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria</title><author>Tomoeda K</author><journal>Mol Genet Metab</journal><year>2000</year><book /><volume>71</volume><number>3</number><pages>506-510</pages><co_aut>et al.</co_aut></literature><literature><id>2477</id><title>Long-term follow up of a new case of hawkinsinuria</title><author>Lehnert W</author><journal>Eur J Pediatr</journal><year>1999</year><book /><volume>158</volume><number>7</number><pages>578-582</pages><co_aut>et al.</co_aut></literature><literature><id>121</id><title>Hypertyrosinemia</title><author>Mitchell GA</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>0</number><pages>1077-1106</pages><co_aut>et al.</co_aut></literature><literature><id>352</id><title>Hawkinsinuria: a dominantly inherited defect of tyrosine metabolism with severe effects in infancy</title><author>Wilcken B</author><journal>N Engl J Med</journal><year>1981</year><book /><volume>305</volume><number>0</number><pages>865</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>